High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
about
sameAs
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveJupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritisCaloric Restriction as a Strategy to Improve Vascular Dysfunction in Metabolic DisordersIssues in solid-organ transplantation in children: translational research from bench to bedside.Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular diseaseRole of C-reactive protein in cardiovascular diseaseC-reactive protein, cardiovascular disease and stroke: new roles for an old biomarkerThe role of inflammation and infection in the pathogenesis and evolution of coronary artery diseaseC-reactive protein: the pawn has been promoted to queenA community study of the effect of particulate matter on blood measures of inflammation and thrombosis in an elderly populationCritical appraisal of C-reactive protein throughout the spectrum of cardiovascular diseaseTumor necrosis factor receptor levels are associated with carotid atherosclerosisNight shift work and inflammatory markers in male workers aged 20-39 in a display manufacturing companySecondhand Smoke Exposure and Subclinical Cardiovascular Disease: The Multi-Ethnic Study of AtherosclerosisBlood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicabilityEndothelial damage due to air pollutionRole of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes.Arterial distensibility in chronic inflammatory rheumatic disordersA high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing.C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.Impact of multiple cardiovascular risk factors on carotid intima-media thickness and elasticity.The atherosclerotic heart disease and protecting properties of garlic: contemporary data.Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.Effect of acute sleep deprivation on vascular function in healthy subjects.PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study.The effect of quercetin on plasma oxidative status, C-reactive protein and blood pressure in women with rheumatoid arthritis.Serum biomarkers in patients with ossification of the posterior longitudinal ligament (OPLL): Inflammation in OPLLA Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo.Serum C-reactive protein and procalcitonin kinetics in patients undergoing elective total hip arthroplasty.Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apneaPlasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort studyImpact of leisure-time physical activity on glycemic control and cardiovascular risk factors in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.Implications of genetic polymorphisms in inflammation-induced atherosclerosisFenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndromeSoluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: the northern Manhattan studyA plant-based diet for the prevention and treatment of type 2 diabetes.
P2860
Q24594814-8FEF435B-5B14-4C51-ABE0-AD2E10BA1A7CQ24630160-16D90479-C275-4B3D-AB71-005D66D587D7Q24801010-D882ACA6-6133-4800-AC73-A35D72B9FBBAQ26744463-EC590655-66A8-4E8A-BBCE-855C2C59422DQ27023312-87078E43-C677-46EE-9539-16AAC4B575C4Q28075372-3818FE98-A5C4-487E-B61E-6CD89F18C01BQ28166927-E6D23A04-8A9F-4A8D-82C5-9A19FCDBE3E2Q28174368-9AC91E74-05B5-4CB5-A078-63F7388AC6BAQ28193154-EC7968B7-995B-4089-8505-89166725D38FQ28194885-D2D0F795-C13B-4A80-A511-C087DDE5ADA6Q28218660-FFC5CD9C-BEBB-4953-91F5-B0D3CA18A2F2Q28219483-3AD03355-C418-4A58-A14F-BF7774A9D436Q28344629-AEA46250-12F3-43B3-8025-75D70F380A4BQ28389703-08CFEF31-A836-4CEC-A073-9C72F97B685CQ28397665-848B007A-9A98-4822-8101-E39F0F68DA0AQ28604099-4474D564-0841-494F-803D-2C2312483DE3Q28744360-BAB12688-46AA-40B4-86CB-55CE547C9B2DQ30310670-B0A9CEA5-0C96-4985-A64F-2EB80F7B0CDEQ30481548-143260CE-702B-4D77-91A8-49E795CE89D4Q30494320-68CBEEB8-BD82-46E6-81A8-F2C411C62C89Q30763122-6CDEA539-302B-4966-B743-9BF6CAF9FC68Q31035233-B1414059-1D9C-4443-9F33-7B1F0B5FBD30Q31082889-E4B91C74-9A32-4CB1-BB33-631C586A6306Q31123022-6D120856-4884-4531-A5A4-0BB65EE844F0Q31134497-89D2C851-F046-4C26-B761-F57FDE747814Q31151097-73F63BB6-BCC6-4465-A29F-CCA38604247AQ33515870-1EBB2CC8-D969-4C73-9EF6-567F56003457Q33572702-29A22DB4-D88F-4534-B206-B0C3C554E7BEQ33592321-0AE1934A-8980-45AC-A31A-69A37CB8098AQ33600869-352F8A9F-9A7F-4978-85A8-990F0E6B062FQ33632234-A01C519E-98A7-4F54-907A-5E9DCBAA51C2Q33633625-6CB1586B-F94D-40FC-9BB8-C3A61CF756E8Q33634769-759BF260-B082-4B20-B7E0-3D85594D1266Q33650343-6F66CE5B-B505-411E-A471-B3320EA1792DQ33699467-6EA4FDE4-E1B5-4E03-9481-E0CB16E97AC6Q33712258-6418A7C3-A16D-42A5-9E75-325CEFEFA2F3Q33735122-5C450EB4-930C-43B4-911F-7435A6C3AA9BQ33736139-E07533AE-F393-49B5-9226-262D8F02B042Q33765516-5412E612-272B-4C9A-AF3B-C3ED2171AA6FQ33785577-3D11C211-397E-4D43-93F5-47B347636AAE
P2860
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@ast
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@en
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@nl
type
label
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@ast
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@en
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@nl
prefLabel
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@ast
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@en
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@nl
P3181
P1433
P1476
High-sensitivity C-reactive pr ...... tion of cardiovascular disease
@en
P2093
P M Ridker
P304
P3181
P356
10.1161/01.CIR.103.13.1813
P407
P577
2001-04-03T00:00:00Z